Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Photoreceptor avascular privilege is shielded by soluble VEGF receptor-1
Authors
Keywords
-
Journal
eLife
Volume 2, Issue -, Pages -
Publisher
eLife Sciences Publications, Ltd
Online
2013-06-19
DOI
10.7554/elife.00324
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeted Intraceptor Nanoparticle Therapy Reduces Angiogenesis and Fibrosis in Primate and Murine Macular Degeneration
- (2013) Ling Luo et al. ACS Nano
- Effect of low dose bisphenol A on the early differentiation of human embryonic stem cells into mammary epithelial cells
- (2013) Linqing Yang et al. TOXICOLOGY LETTERS
- Soluble FLT1 Binds Lipid Microdomains in Podocytes to Control Cell Morphology and Glomerular Barrier Function
- (2012) Jing Jin et al. CELL
- AAV2-Mediated Subretinal Gene Transfer of mIL-27p28 Attenuates Experimental Autoimmune Uveoretinitis in Mice
- (2012) Ju Shao et al. PLoS One
- Basic and Therapeutic Aspects of Angiogenesis
- (2011) Michael Potente et al. CELL
- DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration
- (2011) Hiroki Kaneko et al. NATURE
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- Age-Related Retinopathy in NRF2-Deficient Mice
- (2011) Zhenyang Zhao et al. PLoS One
- Short DNA sequences inserted for gene targeting can accidentally interfere with off-target gene expression
- (2010) Ingo D. Meier et al. FASEB JOURNAL
- Inhibition of Choroidal Neovascularization in a Nonhuman Primate Model by Intravitreal Administration of an AAV2 Vector Expressing a Novel Anti-VEGF Molecule
- (2010) Michael Lukason et al. MOLECULAR THERAPY
- Proteases and sFlt-1 Release in the Human Placenta
- (2010) S. Zhao et al. PLACENTA
- Combined cataract extraction and intravitreal bevacizumab in eyes with choroidal neovascularization resulting from age-related macular degeneration
- (2009) Claudio Furino et al. JOURNAL OF CATARACT AND REFRACTIVE SURGERY
- Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography
- (2009) Marco Ruggeri et al. OPTICS EXPRESS
- An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris
- (2009) M. Saint-Geniez et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis
- (2009) F. Zhang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reduction of Endogenous Angiogenesis Inhibitors in Bruch's Membrane of the Submacular Region in Eyes With Age-Related Macular Degeneration
- (2008) Imran A. Bhutto ARCHIVES OF OPHTHALMOLOGY
- Implications of bevacizumab on vascular endothelial growth factor and endostatin in human choroidal neovascularisation
- (2008) O Tatar et al. BRITISH JOURNAL OF OPHTHALMOLOGY
- The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching
- (2008) Nicholas C. Kappas et al. JOURNAL OF CELL BIOLOGY
- Sequence- and target-independent angiogenesis suppression by siRNA via TLR3
- (2008) Mark E. Kleinman et al. NATURE
- Time Course of Morphologic Effects on Different Retinal Compartments after Ranibizumab Therapy in Age-related Macular Degeneration
- (2008) Christian Ahlers et al. OPHTHALMOLOGY
- Endogenous VEGF Is Required for Visual Function: Evidence for a Survival Role on Müller Cells and Photoreceptors
- (2008) Magali Saint-Geniez et al. PLoS One
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started